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ABSTRACT
The effects were investigated of cyclical rhythm and hormonal contra-
ception on serum fat-mobilizing activity, glycerol, cholesterol and whole
blood glucose during 2 menstrual cycles in a group of normaJly menstruat-
ing young women and a second group of young women using hormonal
contraception. A control group of normal young men was also investigated.
There was no evidence of any change in mean level of any of the para-
meters measured, among the fo1\icular, ovulatory and luteal phases. No
cyclical pattern was discernable in the male subjects. The mean value for
serum cholesterol concentration in women using hormonal contraception
was higher than the value for the untreated human female group. The
overal1 mean value for serum glycerol concentration in the women was
significantly (0.01 > P > 0.001) higher than the mean value obtaining
in the men.
Serum and plasma possess the capacity to mobilize triglyceride from adipose
tiss'u~ incubated ill vitro (Recant et al. 1963; Bums et ai. 1967; Curtis-Prior
1973): The potency of the fat-mobilizing factor has been shown to be adequate
for the fulfilling of normal energy demands in terms of free fatly acid (FFA)
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Ponderal Skin fold Normal
Subject Age Height Weight index thickness cycle length
(years) (m) (kg) (cm) (days)
20 1.65 53.1 13.3 1.0 28
2 24 1.69 52.2 13.9 1.9 30
3 24 1.68 61.7 12.7 1.9 28
4 28 1.73 56.3 13.9 0.9 28
5 22 1.60 62.1 12.1 2.3 30
6 24 1.57 54.0 12.6 2.3 30
7 30 1.52 54.0 12.2 2.0 26
Mean
values 24.6 :!: 1.3 1.63:!:: 0.03 56.2:!:: 1.6 13.0 :!: 0.3 1.8 :!: 0.2 28.6 :!: 0.6
:!: SD!
Subject Age Height Weight Ponderal Skin foldindex thickness
(years) (m) (kg) (cm)
12 26 1.73 56.7 13.9 0.5
13 28 1.75 64.9 13.3 0.6
14 24 1.83 75.8 13.1 0.7
15 31 1.73 77.1 12.4 1.2
Mean values:!: SD! 27:!: 1.5 1.7 6 :!: 0.02 68.6 :!: 4.8 13.2 :!: 0.3 0.75 :t 0.16
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Table 1 a.
Basic data of Sub-group A - normal women.
availability from adipose reserves in the rat (Cllrtis-Prior 8: Hanley 1973).
Since plasma FFA concentrations are increased during the luteal phase of
the menstrual cyc1e (Reinke et al. 1972) and under conditions of hormonal
contraception (Seng et al. 1969; Wynn et al. 1966) it was decided to foJlow
Table 1 c.
Basic data of Sub-group C - normal men.
Subj eel Age Height Weight Ponderal Skin fold Normal Contraceptiveindex thickness cycle length therapy
(years) (m) (kg) (em) (days) (Proprietary name)
c.>:> 8 30 1.70 63.5 12.9 2.2 28 Eugynonc.>:>to
9 26 1.57 53.9 12.6 1.2 28 Minovlar
10 22 1.62 56.7 13.1 1.2 30 Orthonovmn
11 26 1.57 54.4 12.6 1.1 28 Gynovlar
Mean values:!: SEM 26:!: 1.6 1.62 :!: 0.03 57.1 :!: 2.2 12.8 :!: 0.1 1.4 :!: 0.3 28.5 :!: 0.5
Table 1 b.
Basic data of Sub-group n - normal women using hormonal contraception.
~
the activity of the fat-mobilizing factor, in serum, during the menstrual cycle
in normal women, women using hormonal contraception and a control group
of normal men. It was also planned to correlate observed changes in serum
fat-mobilizing activity with possible fluctuations in circulating levels of glyc-
erol, glucose and cholesterol.
MATERIALS AND METHODS
Human subjects
Volunteers were selected from the scientific and technical staff of the hospital
campus to form an approximately homogenous group as regards height. weight and age.
The general group was sub-divided as indicated to form: Sub-group A - normal women
(Table 1 a), Sub-group B - normal women using hormonal contraception (Table 1 b),
and Sub-group C - normal men (Table 1 c).
The basic data obtained from the volunteers included skinfold thickness (SFT) and
their ponderal index (P. 1.), which is calculated as height in inches divided by the
cube root of body weight in pounds (Seltzer 19(6). These data provided further evi-
dence of the homogeneity of the volunteer group as a whole.
Blood samPling
Sampling was carried out during the follicular. ovulatory and luteal phases of
menstruation over a period of 2 cycles. The male subjects were sampled weekly for
. 8 weeks. After an overnight fast. 20 ml of blood was on each occasion withdrawn
from either left or right cubital vein. Two ml of wIlDIe blood was used for glucose
determination by a glucose oxidase method (Huggett So:Nixon 1957). and the re-
maining blood allowed to clot for GOmin at room temperature and 60 min at +4°C.
Portions of the serum obtained following centrifugation were used for estimation
of free glycerol (Wt'iland 19(3) and cholesterol (Levine So:Zak 1964). The residual
bulk of serum was stored frozen at -20°C prior to bioassay for lipolytic activity.
Assay for liPolytic activity
Rat isolated fat cells were prepared in Krebs-Ringer bicarbonate buffer (pH 7.4
containing glucose 45 mg/l00 ml and human albumin 3.5 gl100 ml) as described
ppreviously (Cllrtis-Prior 1972). The fat-mobilizing activity of 1.10 ml of serum
(in triplicate) previously shown to be the maximally effective concentration (Cllrtis- .
Prior 8: Han/ey 1973) was determined by using glycerol production during a 90 min
incubation as the index of lipolysis. The number of nanomoles of glycerol released
was expressed in terms of the weight of total intracellular lipid determined by a
modified Fo/ell et ai. (1957) technique (Curtis-Prior et al. 19(9).
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FMA (nmoles Glycerol Glucose Cholesterol
Phase mg-I/90 min) (nmol/ml) (mg/IOO ml (mg/IOO ml)
whole blood)
Parameter
Sub-group
FMA (nmol Glycerol Glucose Cholesterol
mg-I/90 min) (nmol/ml) (mg/l00 ml) (mg/10D ml)
A normal women 10.6 :!: 0.7 105.9 :!: 12.3 74.8 :!: 1.8 191.4 :!: 8.4
B normal women
using hormonal
contraception 10.9 :!: D.4 83.6 :!: 12.5 74.1 :!: 2.1 223.7 :!: 13.1
C normal men 10.2 :!: 1.1 48.0:!: 7.9 74.1 :!: 5.3 214.8 :!: 13.8
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Table 2.
Serum fat-mobilizing activity (FMA), glycerol, cholesterol and blood glucose levels
during different phases of the menstrual cycle.
Sub-grollp A (normal women, mean of 7 mbjects :!: SEll)
Follicular
Ovulatory
Luteal
10.5 :!: 0.8
10.2 :!: 0.8
11.0 :!: 0.9
105.8 :!: 14.2
111.1 :!: 11.6
100.8 :!: 14.4
73.3 :!: 2.0
75.7 :!: 2.4
75.4 :!: 2.2
191.8 :!: 9.2
195.1 :!: 7.0
187.2 :!: 10.4
Sub-group B (normal women !ISing hormonal cOlztraceptioll, meall of 4 subjects:!: SEM)
Follicular
Ovulatory
Luteal
10.8 :!:0.5
11.9 :t 0.8
10.1 :!: 0.9
79.5 :!: 9.6
88.0 :!: 16.0
82.5 :!: 14.5
73.8 :!: 2.3
72.6 :!: 3.1
75.9 :!: 1.3
229.5 :!: 9.7
221.0 :!: 11.7
220.5 :!: 18.2
RESULTS
The data in Table 2 show serum fat-mobilizing activity (FMA), glycerol,
glucose and cholesterol levels during different phases of the menstrual cycle
for normal women (Sub-group A) and normal women using hormonal contra-
ception (Sub-group B). Analysis of variance using a two-factor model (subjects
and phase of the menstrual cycle) showed no evidence of any change in mean
Table 3.
Overall mean values:!: SD! for each of the parameters measured within each Sub-group.
levels of any of the parameters measured, among the follicular, ovulatory
and luteal phases. The factor "phases" was therefore ignored, and the 3 values
for each subject were regarded as merely within-subject variation in a re-
calculation of the data to produce a single value for each parameter shown in
Table 3. Lack of evidence of any cyclic pattern in Sub-group C subjects
(normal. men) also allowed compilation of these data to a single value for
each parameter as shown in Table 3.
There was a difference between the overall mean values of serum cholesterol
for Sub-grouup A (normal women) and Sub-group B (normal women using
hormonal contraception). However, this difference was only at the 7 Ofo level
of statistical significance. 'When Sub-groups A and B were combined and
compared with Sub-group C, the only significant difference was for serum
glycerol levels. Sub-group C gave a much lower value than Sub-groups A and B
combined (0.01 > P> 0.001).
DISCUSSION
The lack of differences in free glycerol and glucose levels at different stages
of the menstrual cycle, is in agreement with the work of others (Kaffamik
et ai. ] 969; Reinke et ai. ]972). Reinke et ai. (1972) observed a significant rise
in FFA, associated with elevated progesterone levels, during the luteal phase
of the cycle. If this is the result of increased adipose tissue lipolysis, then
elevation in circulating glycerol level would also be expected to occur, and
increased activity of the serum lipolytic factor might be expected; neither
of these phenomena was observed.
Raised serum cholesterol values in women using hormonal contraception
have been reported previously (Wynn et at. 1966). Stokes & Wynn (1971)
showed that the most 'progestational' formulations resulted in the highest
cholesterol values, whereas the most oestrogenic led to the highest triglyceride
values.
The highly significant difference (0.01 > P> 0.001), between the serum
glycerol concentrations of women (Sub-groups A and B taken together) and
men (Sub-group C) is a most surprising finding. The normal human range of
values for serum glycerol has been reported (Eggstein 1966) to be 0.5-1.7
mg/lOO ml of serum, approximately equivalent to 54-185 nmol/ml of serum.
Therefore, the women tend to life towards the upper end of the range (97.8 :!:
9.3 nmol/ml) and the men at the lower end (48.0 :t 7.9 nmol/ml). \Ve can find
no other report of such a sex difference. It is difficult to reconcile this picture
with the higher incidence of atherosclerosis in men compared with women,
which is presumably due, at least in part, to higher levels of circulating lipid,
rather than lower.
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